SUNPHARMA — Sun Pharmaceutical Industries Share News
0.000.00%
- IN₹4.51tn
- IN₹4.19tn
- IN₹584.62bn
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India's Sun Pharma rises as quarterly profit before exceptional items and tax increases
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong (updated)
India's Sun Pharma posts lower quarterly profit on one-time acquisition-related charge
Brief: Sun Pharma Q2 Consol Net PAT 19.89 Billion Rupees
Preview: India's Sun Pharma rises as analysts expect specialty portfolio to power Q2 growth
India Stocks: Indian shares inch higher on IT rally, earnings-led rebound; oil caps gains
India Stocks: Indian shares open flat as IT rally, earnings-led rebound counter higher oil prices
Brief: Sun Pharma Says USFDA Approved The Supplemental Biologics License Application For Ilumya
Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
India's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
India New Issue-Sun Pharma accepts bids for bond issues, bankers say
Brief: Sun Pharma Says Unloxcyt Receives Category 2A Designation In NCCN Guidelines For LACSCC
India New Issue-Sun Pharma to issue over five-year bonds, bankers say